These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33406123)

  • 1. Development of an orally-administrable tumor vasculature-targeting therapeutic using annexin A1-binding D-peptides.
    Nonaka M; Mabashi-Asazuma H; Jarvis DL; Yamasaki K; Akama TO; Nagaoka M; Sasai T; Kimura-Takagi I; Suwa Y; Yaegashi T; Huang CT; Nishizawa-Harada C; Fukuda MN
    PLoS One; 2021; 16(1):e0241157. PubMed ID: 33406123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted drug delivery to tumor vasculature by a carbohydrate mimetic peptide.
    Hatakeyama S; Sugihara K; Shibata TK; Nakayama J; Akama TO; Tamura N; Wong SM; Bobkov AA; Takano Y; Ohyama C; Fukuda M; Fukuda MN
    Proc Natl Acad Sci U S A; 2011 Dec; 108(49):19587-92. PubMed ID: 22114188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor vasculature-targeted
    Yoneyama T; Hatakeyama S; Sutoh Yoneyama M; Yoshiya T; Uemura T; Ishizu T; Suzuki M; Hachinohe S; Ishiyama S; Nonaka M; Fukuda MN; Ohyama C
    BMC Cancer; 2021 Jan; 21(1):72. PubMed ID: 33446132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IF7-Conjugated Nanoparticles Target Annexin 1 of Tumor Vasculature against P-gp Mediated Multidrug Resistance.
    Yu DH; Liu YR; Luan X; Liu HJ; Gao YG; Wu H; Fang C; Chen HZ
    Bioconjug Chem; 2015 Aug; 26(8):1702-12. PubMed ID: 26076081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor targeting by a carbohydrate ligand-mimicking peptide.
    Hatakeyama S; Shibata TK; Tobisawa Y; Ohyama C; Sugihara K; Fukuda MN
    Methods Mol Biol; 2013; 1022():369-86. PubMed ID: 23765676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retro-inverso carbohydrate mimetic peptides with annexin1-binding selectivity, are stable in vivo, and target tumor vasculature.
    Chen X; Fan Z; Chen Y; Fang X; Sha X
    PLoS One; 2013; 8(12):e80390. PubMed ID: 24312470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A d-Peptide Ligand of Integrins for Simultaneously Targeting Angiogenic Blood Vasculature and Glioma Cells.
    Ren Y; Zhan C; Gao J; Zhang M; Wei X; Ying M; Liu Z; Lu W
    Mol Pharm; 2018 Feb; 15(2):592-601. PubMed ID: 29283582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography imaging of a novel Anxa1-targeted peptide
    Chen F; Xiao Y; Shao K; Zhu B; Jiang M
    J Labelled Comp Radiopharm; 2020 Oct; 63(12):494-501. PubMed ID: 32562502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting prion-like protein doppel selectively suppresses tumor angiogenesis.
    Al-Hilal TA; Chung SW; Choi JU; Alam F; Park J; Kim SW; Kim SY; Ahsan F; Kim IS; Byun Y
    J Clin Invest; 2016 Apr; 126(4):1251-66. PubMed ID: 26950422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and Characterization of Homing Peptides Using In Vivo Peptide Phage Display.
    Hyvönen M; Laakkonen P
    Methods Mol Biol; 2015; 1324():205-22. PubMed ID: 26202272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming the blood-brain barrier by Annexin A1-binding peptide to target brain tumours.
    Nonaka M; Suzuki-Anekoji M; Nakayama J; Mabashi-Asazuma H; Jarvis DL; Yeh JC; Yamasaki K; Akama TO; Huang CT; Campos AR; Nagaoka M; Sasai T; Kimura-Takagi I; Suwa Y; Yaegashi T; Shibata TK; Sugihara K; Nishizawa-Harada C; Fukuda M; Fukuda MN
    Br J Cancer; 2020 Nov; 123(11):1633-1643. PubMed ID: 32921792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A therapeutic antibody targeting annexin-A1 inhibits cancer cell growth in vitro and in vivo.
    Al-Ali HN; Crichton SJ; Fabian C; Pepper C; Butcher DR; Dempsey FC; Parris CN
    Oncogene; 2024 Feb; 43(8):608-614. PubMed ID: 38200229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ANXA1 Binds and Stabilizes EphA2 to Promote Nasopharyngeal Carcinoma Growth and Metastasis.
    Feng J; Lu SS; Xiao T; Huang W; Yi H; Zhu W; Fan S; Feng XP; Li JY; Yu ZZ; Gao S; Nie GH; Tang YY; Xiao ZQ
    Cancer Res; 2020 Oct; 80(20):4386-4398. PubMed ID: 32737118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced antitumor effect of combination of annexin A1 knockdown and bortezomib treatment in multiple myeloma in vitro and in vivo.
    Jia C; Kong D; Guo Y; Li L; Quan L
    Biochem Biophys Res Commun; 2018 Nov; 505(3):720-725. PubMed ID: 30292410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and application of elastin like polypeptide containing IL-4 receptor targeting peptide.
    Sarangthem V; Cho EA; Bae SM; Singh TD; Kim SJ; Kim S; Jeon WB; Lee BH; Park RW
    PLoS One; 2013; 8(12):e81891. PubMed ID: 24339977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Annexin 1 induced by anti-inflammatory drugs binds to NF-kappaB and inhibits its activation: anticancer effects in vitro and in vivo.
    Zhang Z; Huang L; Zhao W; Rigas B
    Cancer Res; 2010 Mar; 70(6):2379-88. PubMed ID: 20215502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiangiogenic targeting liposomes increase therapeutic efficacy for solid tumors.
    Chang DK; Chiu CY; Kuo SY; Lin WC; Lo A; Wang YP; Li PC; Wu HC
    J Biol Chem; 2009 May; 284(19):12905-16. PubMed ID: 19276080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the AnxA1/FPR1 autocrine axis reduces MDA-MB-231 breast cancer cell growth and aggressiveness in vitro and in vivo.
    Vecchi L; Alves Pereira Zóia M; Goss Santos T; de Oliveira Beserra A; Colaço Ramos CM; França Matias Colombo B; Paiva Maia YC; Piana de Andrade V; Teixeira Soares Mota S; Gonçalves de Araújo T; Van Petten de Vasconcelos Azevedo F; Soares FA; Oliani SM; Goulart LR
    Biochim Biophys Acta Mol Cell Res; 2018 Sep; 1865(9):1368-1382. PubMed ID: 29932988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting of tumor blood vessels: a phage-displayed tumor-homing peptide specifically binds to matrix metalloproteinase-2-processed collagen IV and blocks angiogenesis in vivo.
    Mueller J; Gaertner FC; Blechert B; Janssen KP; Essler M
    Mol Cancer Res; 2009 Jul; 7(7):1078-85. PubMed ID: 19584266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel vascular-targeting peptide for gastric cancer delivers low-dose TNFα to normalize the blood vessels and improve the anti-cancer efficiency of 5-fluorouracil.
    Lu L; Li ZJ; Li LF; Shen J; Zhang L; Li MX; Xiao ZG; Wang JH; Cho CH
    Peptides; 2017 Nov; 97():54-63. PubMed ID: 28970092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.